Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared Emmanuel J Favaloro‘s post on LinkedIn, adding:
”Pleased to see our recent work on Emicizumab in Acquired Hemophilia A published in Seminars in Thrombosis and Hemostasis and shared by the Editor-in-Chief, Prof. Emmanuel J. Favaloro.
In this study we report real-world clinical experience and patient-level outcomes on the use of Emicizumab in a rare and complex bleeding disorder.
Our findings highlight its potential role in improving bleeding control and reducing hospitalization in selected patients with Acquired Hemophilia A.
Rare diseases require rigorous research, careful clinical judgment, and strong collaboration across centers.
Grateful to all colleagues who contributed to this work.”
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn about a recent article by Ilenia Calcaterra et al, published in Seminars in Thrombosis and Hemostasis:
”Emicizumab in Acquired Hemophilia A.
Recently released online in Seminars in Thrombosis and Hemostasis.
Enjoy!”
Title: Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis
Authors: Ilenia Calcaterra, Carmine De Luca, Guido D’Errico, Ciro Miele, Chiara Caputo, Raffaele Russo, Paolo Conca, Ernesto Cimino, Anna Guida, Antonella Tufano, Matteo Di Minno
Read the Full Article on Seminars in Thrombosis and Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 21, 2026, 11:50Khalil Ahmad: The Incredible Journey of a Red Blood Cell – A Lifelong Mission of Oxygen Delivery
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:50Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition
-
Jun 21, 2026, 07:39Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies
-
Jun 21, 2026, 07:24Seema Dawood: The Power of Blood Smear Confirmation in Detecting Immature Granulocytes
-
Jun 21, 2026, 05:32Flora Peyvandi: Characterizing Acquired VWD Through a Large Patient Cohort
-
Jun 21, 2026, 05:23Mohammed Alo: The Gap Between Nattokinase Marketing and Evidence
-
Jun 21, 2026, 05:11Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar N63